Pharmacoeconomic and clinical implications of sequential therapy for metastatic renal cell carcinoma patients in Central and Eastern Europe.

Vrdoljak, E

Pharmacoeconomic and clinical implications of sequential therapy for metastatic renal cell carcinoma patients in Central and Eastern Europe. [electronic resource] - Expert opinion on pharmacotherapy 2016 - 93-104 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1744-7666

10.1517/14656566.2016.1107043 doi


Antineoplastic Agents--economics
Carcinoma, Renal Cell--drug therapy
Cost-Benefit Analysis
Economics, Pharmaceutical
Europe, Eastern
Humans
Kidney Neoplasms--drug therapy
Reimbursement Mechanisms
Turkey